Hypothesis

3 Matching Annotations

Oct 2025
www.sciencedirect.com www.sciencedirect.com

A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity

1
1. scibot 09 Oct 2025
  
  in Public
  
  RRID:AB_281082
  
  DOI: 10.1016/j.xcrm.2025.102409
  
  Resource: None
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:AB_2810821
  
  What is this?
  
  RRIDCUR:Unresolved RRID:AB_2810821
Visit annotations in context

Tags

RRIDCUR:Unresolved

RRID:AB_2810821

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125004823
Aug 2025
www.sciencedirect.com www.sciencedirect.com

Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

1
1. scibot 26 Aug 2025
  
  in Public
  
  RRID:AB_2810821
  
  DOI: 10.1016/j.ccell.2025.07.021
  
  Resource: (BioLegend Cat# 982312, RRID:AB_2810821)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2810821
  
  What is this?
  
  RRID:AB_2810821
Visit annotations in context

Tags

RRID:AB_2810821

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610825003277
Aug 2024
www.sciencedirect.com www.sciencedirect.com

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD

1
1. scibot 21 Aug 2024
  
  in Public
  
  AB_2810821
  
  DOI: 10.1016/j.ccell.2024.07.007
  
  Resource: (BioLegend Cat# 982312, RRID:AB_2810821)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2810821
  
  What is this?
  
  RRID:AB_2810821
Visit annotations in context

Tags

RRID:AB_2810821

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824002721